Baird analyst David Rescott lowered the firm’s price target on Nevro to $23 from $26 and keeps a Neutral rating on the shares. The firm noted 2Q23 came in slightly above the previously lowered guide, but 3Q23 and FY23 guidance came in meaningfully below our/CNS expectations.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on NVRO:
- Nevro sees Q3 revenue $95M-$97M, consensus $109.25M
- Nevro lowers FY23 revenue view to $410M-$415M from $445M-$455M
- Nevro reports Q2 EPS (69c), consensus (69c)
- Nevro Reports Second Quarter 2023 Financial Results, Provides Third Quarter Guidance and Updates Full-Year 2023 Guidance
- NVRO Upcoming Earnings Report: What to Expect?
